Results 11 to 20 of about 248,256 (115)

Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

open access: yesFrontiers in Physiology, 2023
Duchenne muscular dystrophy (DMD) is a severe, progressive, and ultimately fatal disease of skeletal muscle wasting, respiratory insufficiency, and cardiomyopathy.
Addeli Bez Batti Angulski   +6 more
semanticscholar   +1 more source

Risdiplam in Type 1 Spinal Muscular Atrophy.

open access: yesNew England Journal of Medicine, 2021
BACKGROUND Type 1 spinal muscular atrophy is a rare, progressive neuromuscular disease that is caused by low levels of functional survival of motor neuron (SMN) protein. Risdiplam is an orally administered, small molecule that modifies SMN2 pre-messenger
G. Baranello   +16 more
semanticscholar   +1 more source

Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis

open access: yesOrphanet Journal of Rare Diseases, 2020
Background Duchenne Muscular Dystrophy (DMD) is a rare disorder caused by mutations in the dystrophin gene. A recent systematic review and meta-analysis of global DMD epidemiology is not available.
S. Crisafulli   +5 more
semanticscholar   +1 more source

Social Media Use and Body Dissatisfaction in Adolescents: The Moderating Role of Thin- and Muscular-Ideal Internalisation

open access: yesInternational Journal of Environmental Research and Public Health, 2021
Internalisation of appearance ideals moderates the relationship between exposure to media images and body dissatisfaction. To date, the role of thin- and muscular-ideal internalisation in the context of social media remains under explored, particularly ...
Anh Vuong   +3 more
semanticscholar   +1 more source

Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy

open access: yesJAMA Neurology, 2020
This nonrandomized controlled trial analyzes safety, biological, and functional outcomes associated with the infusion of rAAVrh74.MHCK7.micro-dystrophin gene transfer in a small group of patients with Duchenne muscular dystrophy.
J. Mendell   +19 more
semanticscholar   +1 more source

Ciencias cognitivas y taichi [PDF]

open access: yes, 2011
El present article està dedicat a establir ponts entre les ciències cognitives (més concretament, la visió enactiva de la cognició), i la pràctica del tai-txi, provinent de la Xina.
Redondo Orta, Iván
core   +2 more sources

The “colonization at home/in the house”: spatial and subjective transformations in waste recycling (Córdoba, Argentina) [PDF]

open access: yes, 2014
Este artículo define como ‘colonización de lo doméstico’ a la fase del reciclaje de residuos que se realiza en los hogares, esto es clasificar y/o enfardar papeles y cartones, acopiar hasta el momento de la venta. Para ello, se describe esta actividad en
Vergara, Gabriela del Valle
core   +5 more sources

Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy

open access: yesNeurology, 2020
Objective To report safety, pharmacokinetics, exon 53 skipping, and dystrophin expression in golodirsen-treated patients with Duchenne muscular dystrophy (DMD) amenable to exon 53 skipping.
D. Frank   +14 more
semanticscholar   +1 more source

Eteplirsen in the treatment of Duchenne muscular dystrophy

open access: yesDrug Design, Development and Therapy, 2017
Duchenne muscular dystrophy is a fatal neuromuscular disorder affecting around one in 3,500–5,000 male births that is characterized by progressive muscular deterioration.
K. Lim, R. Maruyama, T. Yokota
semanticscholar   +1 more source

Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review

open access: yesOrphanet Journal of Rare Diseases, 2017
Spinal muscular atrophy linked to chromosome 5q (SMA) is a recessive, progressive, neuromuscular disorder caused by bi-allelic mutations in the SMN1 gene, resulting in motor neuron degeneration and variable presentation in relation to onset and severity.
I. Verhaart   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy